These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2218780)

  • 1. Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension.
    Myburgh DP
    S Afr Med J; 1990 Oct; 78(8):456-7. PubMed ID: 2218780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
    Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
    Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
    Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Leary WP; van der Byl K
    S Afr Med J; 1988 Jul; 74(1):13-5. PubMed ID: 3388151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
    Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
    Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
    Fermé I; Djian J; Tcherdakoff P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily dosing of sustained-release diltiazem capsules in mild-to-moderate hypertension.
    Ginsberg D; Pappas JE; Rofman BA; Gutgsell TL; Schumer B; Karp R; Walker SD
    J Am Osteopath Assoc; 1988 Dec; 88(12):1489-92. PubMed ID: 3248953
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
    Weir MR; Haynie R; Vertes V; Pinson R; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(6):473-81. PubMed ID: 2289216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of slow release diltiazem for essential hypertension in general practice.
    Coulter DM
    N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
    Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
    J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
    Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
    Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the therapeutic efficacy of delayed-action diltiazem in the treatment of mild and moderate hypertension, with ambulatory of blood pressure monitoring].
    Nobre F; Oigman W
    Arq Bras Cardiol; 1994 Oct; 63(4):321-5. PubMed ID: 7771953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release diltiazem and prevention of cardiovascular risk in hypertensive patients.
    Djian J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S20-7. PubMed ID: 1706010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
    Lacourcière Y; Poirier L; Lefebvre J; Burford RG
    Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
    Nikkilä M; Inkovaara J; Heikkinen J
    Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term administration of diltiazem hydrochloride in hypertensive patients.
    Sawai K
    Clin Ther; 1983; 5(4):422-35. PubMed ID: 6871924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.